Last reviewed · How we verify
NCT04510727
Optical Coherence Tomography Guided C&D
NA trial testing Optical Coherence Tomography (OCT) in Basal Cell Carcinoma. Withdrawn.
1 February 2025
Quick facts
| Lead sponsor | University of Miami |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Start date | 1 April 2024 |
| Primary completion | 1 February 2025 |
| Estimated completion | 1 February 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Optical Coherence Tomography (OCT)
- Curettage & Desiccation (C&D) Procedure
Conditions studied
- Basal Cell Carcinoma — all drugs for Basal Cell Carcinoma →
Sponsor
University of Miami
Who can join
18 and older, any sex, with Basal Cell Carcinoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to identify the presence of residual superficial and nodular basal cell carcinoma (BCC) status-post curettage and desiccation (C\&D) by using optical coherence tomography (OCT).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04510727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Optical Coherence Tomography (OCT)
Trials testing the same drug.
- NCT07434362 — Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy · NA · completed
- NCT06976034 — oCular Examination at Cell RESolution With Optical TransmissionTomography · NA · recruiting
- NCT05161546 — Study of Bipolar Disorders and Retinal Electrophysiological Markers · NA · terminated
- NCT04774822 — Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device · completed
- NCT04701385 — Plaque Erosion Prospective Study ii · completed
Other recruiting trials for Basal Cell Carcinoma
Currently open trials in the same condition.
- NCT07182240 — Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Ba · NA · recruiting
- NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
- NCT06600165 — Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma · recruiting
- NCT06384924 — Raman Spectroscopy and Skin Cancer · recruiting
- NCT06384053 — Skin Cancer and Hyperthermia and Radiotherapy · NA · recruiting
Other University of Miami trials
Trials by the same sponsor.
- NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
- NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
- NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
- NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
- NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04510727 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Miami
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04510727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing